Literature DB >> 5167621

Heat stability of influenza viral infectivity as a host-controlled phenotype. Brief report.

M V Haspel, A Sugiura.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 5167621     DOI: 10.1007/BF01249725

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  9 in total

1.  GENETIC STUDIES OF INFLUENZA VIRUSES. II. PLAQUE FORMATION BY INFLUENZA VIRUSES IN A CLONE OF A VARIANT HUMAN HETEROPLOID CELL LINE.

Authors:  A SUGIURA; E D KILBOURNE
Journal:  Virology       Date:  1965-07       Impact factor: 3.616

2.  Host-controlled variation in NDV.

Authors:  J W DRAKE; P A LAY
Journal:  Virology       Date:  1962-05       Impact factor: 3.616

3.  The release of influenza virus from the infected cell.

Authors:  L HOYLE
Journal:  J Hyg (Lond)       Date:  1954-06

4.  Immunochemical study of influenza virus and associated host tissue components.

Authors:  C Howe; L T Lee; A Harboe; G Haukenes
Journal:  J Immunol       Date:  1967-03       Impact factor: 5.422

5.  The polypeptides of influenza virus. II. Interpretation of polyacrylamide gel electrophoresis patterns.

Authors:  E A Haslam; A W Hampson; J A Egan; D O White
Journal:  Virology       Date:  1970-11       Impact factor: 3.616

6.  Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity.

Authors:  P W Choppin
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

7.  The structure of influenza viruses. IV. Chemical studies of the host antigen.

Authors:  W G Laver; R G Webster
Journal:  Virology       Date:  1966-09       Impact factor: 3.616

8.  Influence of lipids on the viral phenotype. I. Interaction of myxoviruses and their lipid constituents with phospholipases.

Authors:  R W Simpson; R E Hauser
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

9.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.